Table 1.
Anthropometric and clinical characteristics of the study sample.
| Parameter | Study Population (N = 93) |
Flaps (N = 31) |
FTSGs (N = 30) |
STSGs (N = 30) |
p |
|---|---|---|---|---|---|
| Male gender (N,%) | 51 (55.0) | 17 (54.8) | 18 (60.0) | 16 (53.3) | 0.861 * |
| Age (years) | 78.6 ± 8.3 | 76.5 ± 7.0 | 79.3 ± 9.0 | 79.8 ± 8.6 | 0.243 † |
| Body height (cm) | 179.1 ± 10.8 | 178.2 ± 9.6 | 177.2 ± 7.5 | 181.0 ± 11.1 | 0.136 † |
| Body mass (kg) | 78.2 ± 8.9 | 77.6 ± 8.7 | 76.5 ± 10.9 | 80.4 ± 6.3 | 0.199 † |
| BMI (kg/m2) | 24.5 ± 2.7 | 24.7 ± 2.8 | 24.1 ± 2.8 | 24.4 ± 2.6 | 0.672 † |
| Time since the op. (mo) | 32 (28–46) | 34 (26–48) | 36 (30–52) | 30 (28–34) | 0.101 ‡ |
| BCC (N,%) | 54 (58.1) | 20 (64.5) | 18 (60.0) | 15 (50.0) | 0.502 * |
| SCC (N,%) | 39 (41.9) | 11 (35.5) | 12 (40.0) | 15 (50.0) | |
| Defect diameter (mm) | 32 (22–44) | 25 (17–32) | 29 (19–33) | 49 (42–54) | <0.001 ‡ |
All data are presented as whole numbers (percentages), mean ± standard deviation or median (interquartile range). Abbreviations: FTSG—full-thickness skin graft; STSG—split-thickness skin graft; BMI—body mass index; BCC—basal cell carcinoma; SCC—squamous cell carcinoma; * chi-square; † one-way analysis of variance (ANOVA) with post hoc Tukey’s test; ‡ Kruskal–Wallis test with post hoc Dunn’s test.